Moreover, previous reports have suggested that HIF1AN negatively regulates the HIF1A/VEGF signaling pathway and both HIF1A and VEGF have been indicated to be upregulated in EM patients [20,31]. This evidence concerns the gene HIF1AN and erythema multiforme.